ClinicalTrials.gov
public full text
Public Domain
The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow
Betahistine may provide benefit by enhancement of Cerebral Blood Flow (CBF). This placebo-controlled pharmacodynamic treatment study will primarily explore the effect of betahistine on cerebral blood flow measured by dynamic contrast-enhanced MRI imaging, in a patient population with MRI evidence of cerebrovascular compromise. Also it will be measured if CBF changes correlate with gait and cognitive changes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment#853790
- Antiseizure Medication in Seizure Networks at Early Acute Brain Injury#893370
- Evaluating the therapeutic impact of early multimodal rehabilitation in hemiplegic stroke patients: A quasi-experimental study.#402816
- Uso do canabidiol como protetor contra disfunções cognitivas associadas ao acúmulo de ferro cerebral em ratos Wistar#946200
- TTI-0102 for Veterans With TBI#859737
Record · ID 845089
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive